Table 1.

Pharmacokinetic characteristics of GSK3277329 in M fascicularis after subcutaneous administration

Nominal dose0.2 mg/kg (n = 2)1 mg/kg (n = 2)15 mg/kg (n = 3)
Cmax, ng/mL 184 (130, 237) 615 (779, 450) 6707 ± 1509 
Tmax, h 1.5 (1.0, 2.0) 0.75 (1.0, 0.5) 
t1/2, h 1.21 (1.13, 1.29) 1.48 (1.96, 1.00) 4.35 ± 0.639 
AUC0-inf, ng × h/mL 662 (425, 899) 2004 (3080, 928) 44 181 ± 10 251 
Nominal dose0.2 mg/kg (n = 2)1 mg/kg (n = 2)15 mg/kg (n = 3)
Cmax, ng/mL 184 (130, 237) 615 (779, 450) 6707 ± 1509 
Tmax, h 1.5 (1.0, 2.0) 0.75 (1.0, 0.5) 
t1/2, h 1.21 (1.13, 1.29) 1.48 (1.96, 1.00) 4.35 ± 0.639 
AUC0-inf, ng × h/mL 662 (425, 899) 2004 (3080, 928) 44 181 ± 10 251 

Means of 2 animals reported for 0.2- and 1-mg/kg dosed animals. Individual values are listed in parentheses. Means and SD values are reported for the 15-mg/kg dose.

AUC, area under the curve; Cmax, maximum serum concentration; inf, infinity; t1/2, half-life; Tmax, time taken to reach maximum concentration.

Close Modal

or Create an Account

Close Modal
Close Modal